Preliminary results from Drug Science’s Project Twenty21 study show medical cannabis improves quality of life by more than 50%.
Under the project, over 900 patients have now received licensed prescriptions for medical cannabis. Drug Science collect and analyse their medical data and using the EQ-5D-5L* rating of quality of life, initial findings show that legally prescribed cannabis provides clinically significant improvements in the quality of life of patients living with conditions such as Chronic Pain, Multiple Sclerosis, Tourette’s Syndrome, Epilepsy, and Post Traumatic Stress Disorder (PTSD).
Prof Mike Barnes has recently been appointed as Clinical Director of Drug Science’s Project Twenty21, the UK’s largest-ever medical cannabis patient study.
Read the results of the latest study in full, authored by C. Sakal, M. Lynskey, A. K. Schlag, D. J. Nutt: Medical Cannabis improves Quality of Life by over 50% - Preliminary Results from Project Twenty21